Risankizumab 150mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £77,777,289 of indicative cost of Risankizumab 150mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 19.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Risankizumab 150mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Risankizumab 150mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Salford Royal Nhs Foundation Trust | £5,767,440 |
| Guy's & St Thomas' Nhs Foundation Trust | £4,290,656 |
| University Hospitals Plymouth Nhs Trust | £4,084,439 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,910,329 |
| Blackpool Teaching Hosp Nhs Found Trust | £2,757,329 |
| Leeds Teaching Hpls Nhs Trust | £2,258,415 |
| Hampshire Hospitals Nhs Foundation Trust | £2,088,785 |
| Royal Free London Nhs Foundation Trust | £1,949,089 |
| Frimley Health Nhs Foundation Trust | £1,859,284 |
| Western Sussex Hospitals Nhs Found Trust | £1,792,763 |
The primary-care picture
Risankizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Risankizumab medicine page.